CRWV (NASDAQ: CRWV) Form 144 lists 200,000-share resale, repeated 10b5-1 sales
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
CRWV submitted a Form 144 reporting the proposed resale of 200,000 shares of Common Stock (conversion of preferred stock). The filing lists numerous 10b5-1 sales executed by multiple holders, including repeated sales by Michael Intrator and Omnadora Capital LLC throughout April–June 2026.
The notice itemizes individual transactions with share counts and gross proceeds; examples include Intrator sales of 200,000 shares on multiple dates and Omnadora Capital LLC sales of approximately 107,692–107,693 shares on matching dates. The filing is a routine resale notice under Section 144.
Positive
- None.
Negative
- None.
Key Figures
Registered/resale amount: 200,000 shares
Example sale — Intrator: 200,000 shares
Example sale — Omnadora Capital LLC: 107,692 shares
+3 more
6 metrics
Registered/resale amount
200,000 shares
preferred stock conversion; listed on the securities-to-be-sold line
Example sale — Intrator
200,000 shares
10b5-1 sale on <date>06/23/2026</date>
Example sale — Omnadora Capital LLC
107,692 shares
10b5-1 sale on <date>06/23/2026</date>
Gross proceeds example
$21,362,820.00
Proceeds reported for Intrator 200,000-share sale on <date>06/23/2026</date>
Fidelity Charitable sale
99,134 shares
sale on <date>05/12/2026</date> with proceeds $10,499,956.05
Small trust example
7,240 shares
Silver Thimble Resulting Trust sale on <date>04/01/2026</date>
Key Terms
Form 144, 10b5-1 sales, preferred stock conversion, gross proceeds
4 terms
Form 144 regulatory
"submitted a Form 144 reporting the proposed resale of 200,000 shares"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 sales regulatory
"the filing lists numerous 10b5-1 sales executed by multiple holders"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
preferred stock conversion financial
"Preferred Stock Conversion | Issuer | 200000 | 02/25/2019"
gross proceeds financial
"individual trade rows include dollar amounts (gross proceeds) for transactions"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.
FAQ
What does CRWV's Form 144 report?
It reports a proposed resale of 200,000 shares of Common Stock. The notice also lists executed 10b5-1 sales by named holders, giving dates, per-trade share counts, and gross proceeds for transactions recorded April–June 2026.
Who are the frequent sellers listed in the CRWV Form 144?
Michael Intrator and Omnadora Capital LLC are the most frequent sellers. The filing shows repeated 10b5-1 sales by both parties, often matching dates and paired share counts (e.g., Intrator ~200,000 shares; Omnadora ~107,692–107,693 shares).
Do the entries show proceeds from the sales in the Form 144?
Yes — the filing lists gross proceeds per transaction. Individual trade rows include dollar amounts (for example, proceeds in the millions for 200,000-share sales), tied to specific sale dates between April and June 2026.
Are the listed sales part of a Rule 10b5-1 plan?
Yes — many entries are explicitly labeled as 10b5-1 sales. The filing repeatedly annotates specific transactions as "10b5-1 Sales," indicating they were executed under prearranged trading plans for the named sellers.